Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc’s coronavirus drug Remdesivir, days after granting emergency approval to the medication the company is supplying as part of its pledged donation.
Japan is expected to lift the state of emergency for 39 of its 47 prefectures on Thursday, local media reported, while the capital Tokyo is set to keep restrictions in place until it sees a convincing containment of the coronavirus.
Senior Olympics officials say the delayed 2021 Tokyo Games are proceeding without Plan B in place.
Coronavirus cases in Asia rose to a quarter of a million on Tuesday, according to a Reuters tally, driven by outbreaks in Singapore, Pakistan and India, even as China, South Korea and Japan significantly slowed the spread of the disease.
Coronavirus patients with light symptoms arriving to stay at several Tokyo hotels are likely to get a lift from a pleasant surprise – a robot greeter in the lobby.